Is Insider Buying a Good Sign? An Honest Look at the Evidence

Short answer: sometimes — but with real limits, and never as a guarantee. Decades of peer-reviewed research find that insider open-market purchases (not sales) have, on average, modestly outperformed the market over the following months — and that the effect is strongest for a narrow, high-conviction subset of insiders, not for insider buying in general. The edge is small, short-lived, concentrated in smaller companies, and shrinks once it’s widely known. Here’s what the evidence actually says, and where it stops.

Everything below describes historical academic research on public SEC filing data. It is informational, not financial advice, and past results do not predict future returns.

What the research finds

Insider trading here means the legal, disclosed kind — corporate insiders reporting their own trades to the SEC on a Form 4. Several large studies have asked whether following those disclosures would have paid off:

• Purchases predict; sales mostly don’t. Lakonishok & Lee (2001), studying over a million trades, found the informative signal comes from insider buying, while insider selling had little predictive power. Jeng, Metrick & Zeckhauser (2003), using a more conservative portfolio method, found insider purchase portfolios earned a positive, statistically significant abnormal return — while insider sales showed no significant edge.
• The signal concentrates in “opportunistic” insiders. Cohen, Malloy & Pomorski (2012), in Decoding Inside Information, showed that most insider trades are routine (predictable, calendar-like) and carry almost no signal. The predictive power sits in the opportunistic, non-routine trades — and in insiders who don’t trade on a schedule. In other words: which insider is buying matters more than the fact that someone is buying.
• More buyers, bigger conviction, senior roles tend to strengthen the signal (cluster buying; larger purchases relative to wealth; CEO/CFO over junior insiders), per Seyhun’s body of work and later studies.

That’s the case for paying attention. Now the honest part.

The catch — why this isn’t a money machine

A signal existing in academic data is very different from a strategy you can profitably run. The same literature is candid about the limits:

• The effect is small and slow. It’s a modest average edge that plays out over months, not overnight — Lakonishok & Lee noted markets barely react when insiders trade or file.
• It’s a short-lived drift. The edge that shows up over a few weeks tends to fade over a few months. It is not a “buy and forget” signal.
• It lives in small, illiquid stocks. The largest measured returns cluster in small-caps — exactly where wide bid-ask spreads and price impact can eat the gain. Studies that cap trade size to realistic amounts find the percentage returns can shrink or vanish after costs.
• Published edges decay. McLean & Pontiff (2016) found anomalies lose a large share of their return after they’re published and widely known. The insider-buying effect has been public for 25+ years.
• Backtests flatter the past. Survivorship, look-ahead bias, data-mining across many variants, and dependence on a single market period can all make a historical result look better than what’s repeatable.

None of this makes insider buying useless. It makes it a research input, not a recommendation — a place to start your own work, not a promise.

So how should you use it? Follow the best insiders, not all of them.

The research points to a clear, practical takeaway: the informative signal isn’t “insiders are buying” — it’s “these particular insiders, with a real track record of well-timed open-market buys, are buying with conviction.” That’s the lens DirectorScope is built around:

• We default to intentional open-market purchases (SEC code P) and filter out the routine, compensation-driven noise.
• We surface each insider’s track record so you can judge credibility for yourself, rather than treating every buy as equal.
• We keep it transparent: every figure traces back to a public SEC filing you can open and read.

That’s a screening and transparency tool — a faster, cleaner way to do your own homework on public data. It is explicitly not a system that promises to beat the market, and nothing here is financial advice.

FAQ

Does insider buying mean a stock will go up? No — there’s no guarantee. Research shows insider purchases have, on average, modestly outperformed historically, but averages hide many losers, the effect is small and short-lived, and the past doesn’t predict the future.

Is insider buying bullish? It’s one bullish data point, strongest when it comes from high-conviction, non-routine buys by insiders with a good track record — and weakest when it’s a single small or routine purchase. Context matters far more than the headline.

Should I buy a stock because an insider bought it? That’s your decision, and this isn’t advice. Insider buying is information to factor into your own research alongside everything else — not a signal to act on by itself.

Why focus on buys and not sells? Insiders sell for many ordinary reasons — taxes, diversification, liquidity, pre-scheduled plans. They generally buy their own stock for only one: they think it’s undervalued. That asymmetry is why buys carry more information.

Research cited: Lakonishok & Lee (2001), Review of Financial Studies; Jeng, Metrick & Zeckhauser (2003), Review of Economics & Statistics; Cohen, Malloy & Pomorski (2012), Journal of Finance; McLean & Pontiff (2016), Journal of Finance; Seyhun, “Investment Intelligence from Insider Trading” (1998). DirectorScope turns public SEC filings into a clean view of intentional insider buying. Informational only — not financial advice.